Stocks and Investing
Stocks and Investing
Wed, November 13, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, November 12, 2019
Chris Schott Upgraded (TEVA) to Hold on, Nov 12th, 2019
Chris Schott of JP Morgan, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold on, Nov 12th, 2019.
Chris has made no other calls on TEVA in the last 4 months.
There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 3 agree with Chris's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Amsellem of "Piper Sandler" Maintained at Hold with Increased Target to $7 on, Friday, November 8th, 2019
- Jacob Hughes of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Monday, September 30th, 2019
- Rohit Vanjani of "Guggenheim" Initiated at Hold on, Thursday, September 12th, 2019
This is the rating of the analyst that currently disagrees with Chris
- David Risinger of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $6 on, Monday, July 15th, 2019
Contributing Sources